MannKind | MNKD - Денежные средства и эквиваленты





Денежные средства и эквиваленты Изменить Дата
Adma Biologics USD 136.02M 2.13M 2026-06
BioCryst Pharmaceuticals USD 154.97M 16.62M 2026-06
Eli Lilly USD 8.95B 3.67B 2026-06
Halozyme Therapeutics USD 163.14M 146.61M 2026-06
Insmed USD 544.76M 37.42M 2026-06
Karyopharm Therapeutics USD 90.85M 30.31M 2026-03
MacroGenics USD 113.91M 47.39M 2026-06
MannKind USD 52.93M 95K 2026-06
Merck USD 6.85B 1.52B 2026-06
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Novavax USD 191.46M 36.9M 2026-06
Novo Nordisk DKK 21.13B 17.81B 2026-03
Pfizer USD 976M 727M 2026-06
Sanofi EUR 6.35B 806M 2026-06
Xencor USD 44.66M 30.49M 2026-06